ALB and Hyperbilirubinemia: This approach underscores the value of multi‐timepoint reporting and the need for standardized outcome measurement intervals in future trials The reduction in phototherapy duration by 1.87 days in the albumin‐treated group underscores the clinical utility of albumin infusion in managing hyperbilirubinemia.